Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Shares Issued (2017 - 2025)

iBio (IBIO) has disclosed Shares Issued for 14 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 83.39% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 91.26% year-over-year, with the annual reading at $113.0 for FY2025, 100.0% down from the prior year.
  • Shares Issued for Q4 2025 was $3.0 million at iBio, up from $30.0 in the prior quarter.
  • The five-year high for Shares Issued was $18.1 million in Q4 2024, with the low at -$1.1 million in Q2 2025.
  • Average Shares Issued over 4 years is $2.3 million, with a median of $88123.0 recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 17960.0% in 2024, then plummeted 125.33% in 2025.
  • Over 4 years, Shares Issued stood at $77000.0 in 2021, then grew by 29.87% to $100000.0 in 2023, then surged by 17960.0% to $18.1 million in 2024, then crashed by 83.39% to $3.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.0 million, $30.0, and -$1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.